openPR Logo
Press release

Morgellons Disease Market Size, Analysis, and Forecast Report 2017-2025

09-21-2017 05:08 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Morgellons Disease Market Size, Analysis, and Forecast

Morgellons disease is a rare, controversial, unexplained skin disorder characterized by crawling, sores, crawling sensations on and below the skin, and fiber-like filaments emerging from the sores. Some medical experts say Morgellons is a physical infection or diseases. While, others experts suggest it is a type of psychosis called "delusional parasitosis," in which patient may feel like something is crawling, biting, or stinging all over and a person thinks parasites have infected their skin. Physicians and patients often misjudge Morgellons symptoms as being parasitic in origin but researchers found that no parasites are involved with the etiology of Morgellons. It has also been found that there are no fungal components to the etiology of Morgellons. Borrelia, a spirochetal bacterium, has been discovered in all Morgellons patients for study so far. Borrelia is identified by multiple methods in large quantity within Morgellons skin lesions including culture.

Request to view Sample Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28208
Morgellons disease is a quite uncommon disorder or illness that most commonly affects middle-aged white women. A number of cases occurred in California, which provoked the CDC to conduct a research study to define if the cases were somehow related. Moreover, another study carried out in London reviewed five years of cases, from 2003 to 2008, and found 18 patients with a diagnosis of mysterious dermopathy or Morgellons. Of these, 83 percent were middle-aged women and 69 percent were white. Cause of disease is still unknown, research on this syndrome has so far not found it to be caused by an infection. It is therefore not transmissible. Moreover, this condition has not been found to be caused by an environmental contaminant.

People who have Morgellons disease report the following signs and symptoms:

Intense itching
Crawling sensations under the skin
Spontaneously–appearing, slow-healing lesions
Seed-like objects/ granules and black specks on/in skin
“Fuzz balls” on/in intact skin
Fine, thread like colored fibers beneath and/or extruding from the skin
Life altering fatigue
Neurological impairment
Visual and hearing changes
Brain fog and diminished higher cognitive abilities
Hair loss
Gastrointestinal changes
Muscle aches, Joint pain
General malaise; intense, life-impacting pain
Dental deterioration
Sleep disturbances
Psychiatric manifestations can include anxiety, depression, new onset of panic attacks, changes in behavior and personality
Difficulty concentrating
Short-term memory loss
At present, there are no diagnostic laboratory tests specifically targeting Morgellons disease. Patient suffering from disease can be identified by medical history, and complaints as well as healthcare provider can ask questions about medical and mental health. Physician can perform a physical examination and may order a variety of lab tests to determine the appropriate diagnosis. Unfortunately, there are no tests currently available that are 100% accurate for diagnosing disease.

While there is no precise treatment for Morgellons disease, individuals who suffer from this disorder have been found to benefit from medications that treat psychosis (Phobia) or tics, like olanzapine (Zyprexa, Zydis, Relprevv) or pimozide (Orap), respectively. Because of the lack of clarity regarding disease symptoms, diagnosis, and potential causes, the prognosis for this disorder is difficult to estimate.

According to the U.S. Centers for Disease Control, "This condition is not currently recognized as a distinct clinical disorder with established diagnostic criteria that are generally accepted by the medical community and many dermatologists consider the condition to be synonymous with delusional parasitosis (DP). To date, most of what is known about the condition is based on isolated case reports or anecdotal accounts. A range of potential infectious (for example, Lyme disease, parasitic) and non-infectious causes has been postulated, but the etiology of this condition remains unknown and there have been no proven effective medical therapies.”

Request to download and view full ToC - https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=28208

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Morgellons Disease Market Size, Analysis, and Forecast Report 2017-2025 here

News-ID: 732864 • Views:

More Releases from Transparency Market Research

Automotive Thermal Management System Market Poised to Reach USD 173.8 Billion by 2036, Driven by EV Adoption and Advanced Thermal Technologies
Automotive Thermal Management System Market Poised to Reach USD 173.8 Billion by …
The global automotive thermal management system market is entering a high-growth phase, fueled by the rapid electrification of vehicles, stricter emission norms, and rising expectations for vehicle safety, comfort, and efficiency. Valued at US$ 82.6 billion in 2025, the market is projected to nearly double and reach US$ 173.8 billion by 2036, expanding at a robust CAGR of 6.8% from 2026 to 2036. Thermal management has become a mission-critical function in
Thermal-Management Exterior Coatings for High-Altitude Aircraft Market to be Worth USD 9.8 Bn by 2036 - By Coating Functionality / By Material / By End-User | U.S. • Canada • Germany • China • India
Thermal-Management Exterior Coatings for High-Altitude Aircraft Market to be Wor …
The global Thermal-Management Exterior Coatings for High-Altitude Aircraft Market was valued at US$ 1.8 Bn in 2025 and is projected to reach US$ 9.8 Bn by 2036, expanding at a robust CAGR of 17.5% during the forecast period from 2026 to 2036. Review critical insights and findings from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86920 This strong growth trajectory reflects the rising importance of advanced exterior coating technologies that ensure aircraft performance, safety,
Epithelioma Treatment Market Outlook 2035: Rising Skin Cancer Burden, Breakthrough Immunotherapies, and an 8.8% CAGR Growth Trajectory
Epithelioma Treatment Market Outlook 2035: Rising Skin Cancer Burden, Breakthrou …
The global epithelioma treatment market has entered a decisive growth phase, supported by rising cancer prevalence and rapid therapeutic innovation. In 2024, the market was valued at US$ 5.1 Bn, reflecting the growing demand for advanced diagnostic and therapeutic solutions targeting epithelial-origin tumors. Over the forecast period from 2025 to 2035, the industry is projected to expand at a robust compound annual growth rate (CAGR) of 8.8%, reaching a valuation
Tablet Hardness Testers Market to Reach USD 427.9 Mn by 2036, Driven by Rising Pharmaceutical Quality Standards
Tablet Hardness Testers Market to Reach USD 427.9 Mn by 2036, Driven by Rising P …
The Tablet Hardness Testers Market is a critical part of the pharmaceutical quality-control ecosystem. Tablet hardness testers are used to measure the mechanical strength of tablets to ensure they can withstand handling, packaging, transportation, and storage without breaking, while still dissolving correctly once ingested. As regulatory oversight becomes stricter and pharmaceutical production expands globally, the demand for accurate and reliable hardness testing equipment continues to rise. The global Tablet Hardness Testers

All 5 Releases


More Releases for Morgellons

Morgellons Disease Market Projected to Reach USD 888.76 Billion by 2031, Growing …
The "Morgellons Disease Market" is a dynamic and rapidly evolving sector, with significant advancements and growth anticipated by 2031. Comprehensive market research reveals a detailed analysis of market size, share, and trends, providing valuable insights into its expansion. This report delves into segmentation and definition, offering a clear understanding of market components and drivers. Employing SWOT and PESTEL analyses, the study evaluates the market's strengths, weaknesses, opportunities, and threats, alongside
The Future is Now and It's Terrifying: Sci-Fi Thriller 'Transhuman' Warns of Tec …
Conspiracies, cutting-edge tech, and a heroine's relentless pursuit of truth collide in the series finale Author Isabella MacLeod brings her captivating series to a breathtaking close with the release of "Transhuman," the thrilling conclusion that takes readers on an unforgettable journey through the realms of science fiction and suspense. "Transhuman" is the final installment in MacLeod's gripping series, which began with "Metamorphosis" in 2015 and continued with "Nano" in 2019. In this
Morgellons Disease Market to Surpass USD 833.73 Million by 2030
Data Bridge Market Research analyses a growth rate in the morgellons disease market in the forecast period 2023-2030. The expected CAGR of the morgellons disease market tends to be around 6.60% in the mentioned forecast period. The market was valued at USD 500 million in 2022, and it would grow up to USD 833.73 million by 2030. In addition to the market insights such as market value, growth rate, market
RNA Markers Market Will Progress at a CAGR of 8.48% by 2029
To uncover the general market conditions and tendencies, RNA Markers Market research report acts as a perfect source. The market report aids in developing a successful marketing strategy for the business. This industry document is a proven source of information which offers a telescopic view of the current market trends, situations, opportunities and status. It has strategically analyzed market research analysis and perceptive business insights into the relevant markets of
Morgellons Video "Star" First Shared Her Story of Triumph, Now Counsels Other Su …
Thousands have watched Connie's video, telling about her story of triumph against Morgellons on YouTube, Google Video, Yahoo Video, MorgellonsHope.com (EwwTube), and several other video sites. She was very excited about the response to her video, stating "I have been symptom-free for six months from a disease known as Morgellons. My experience and my story met with success and my return to a healthy, normal lifestyle after more than a
Morgellons Alert: MD Discovers "Effective Therapy" for Morgellons Syndrome
In an open letter to the Morgellons Community, Dr. Matthews states that he has preliminary data that indicates that a special suspension of Ionized, Colloidal Silver in distilled water, (also known as \"clustered silver\"), \"is an effective therapy for some of the symptoms in some of the patients suffering with Morgellons Syndrome, and endorse trials of its use for this mysterious condition.\" After being exposed to his first Morgellons victim about